Get started
Author

Luca Bollo

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
2020 · Luca Bollo, Tommaso Guerra, et al. · Journal of the Neurological Sciences · 37
PDF
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants
2023 · Simone Beretta, Viviana Cristillo, et al. · Neurology · 35
PDF
Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis
2024 · Wallace J. Brownlee, Angela Vidal‐Jordana, et al. · Annals of Neurology · 31
PDF
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
2022 · Damiano Paolicelli, Maddalena Ruggieri, et al. · Brain Sciences · 19
PDF
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2024 · Luca Bollo, Georgina Arrambide, et al. · Neurology · 14
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis
2023 · Javier Villacieros‐Álvarez, Carmen Espejo, et al. · Annals of Neurology · 14
PDF
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis
2025 · Manuel Comabella, Agustín Pappolla, et al. · Neurology Neuroimmunology & Neuroinflammation · 13
PDF
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
2024 · Javier Villacieros-Álvarez, Jan D. Lunemann, et al. · Neurology Neuroimmunology & Neuroinflammation · 11
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
2021 · Marta Simone, Claudia Palazzo, et al. · Frontiers in Neurology · 10
PDF
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients
2023 · René Carvajal, Carmen Tur, et al. · Multiple Sclerosis Journal · 9
Age-Related Disability Outcomes After a First Demyelinating Event
2025 · Alvaro Cobo-Calvo, Pere Carbonell-Mirabent, et al. · Neurology · 7
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies
2024 · René Carvajal, Breogán Rodríguez-Acevedo, et al. · Multiple Sclerosis Journal · 7
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
2021 · Luca Bollo, Pietro Iaffaldano, et al. · Frontiers in Neurology · 5
PDF
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort
2025 · Andreu Vilaseca, Mar Tintoré, et al. · Multiple Sclerosis Journal · 4
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?
2025 · Andreu Vilaseca, Angela Vidal-Jordana, et al. · Multiple Sclerosis Journal · 3
PDF
Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs
2024 · Agustin Pappolla, Cristina Auger, et al. · Multiple Sclerosis Journal · 3
PDF
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
2021 · Tommaso Guerra, Luca Bollo, et al. · Multiple Sclerosis Journal · 3
Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores
2026 · Victoria Fernández, Agustin Pappolla, et al. · Neurology · 2
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity
2026 · René Carvajal, Marta Ponzano, et al. · JAMA Network Open · 2
Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis
2026 · Luca Bollo, Deborah Pareto, et al. · Multiple Sclerosis Journal · 2
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody–Positive Neuromyelitis Optica Spectrum Disorder
2025 · Javier Villacieros-Álvarez, Maria Sepulveda, et al. · Neurology Neuroimmunology & Neuroinflammation · 2
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient‐Reported Disability Measure and Self‐Administered Neuroperformance Outcomes
2026 · Evy M. Reinders, Ariadna Masot‐Llima, et al. · Annals of Neurology · 1
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study
2025 · Gianmarco Abbadessa, Irene Schiavetti, et al. · Journal of the Neurological Sciences · 1
Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate
2022 · Luca Bollo, Francesca Caputo, et al. · Internal and Emergency Medicine · 1
PDF
Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature review
2022 · Luca Bollo, Carlo Santoro, et al. · Neurological Sciences · 1
PDF
Works count: 42
Citation count: 239
H-index: 9
I10-index: 9
Year
Topic
Type